DR. ANDREW CHRISTOPHER BOYLAN M.D. NPI 1669734786

NPI Details

DR. Andrew Christopher Boylan, M.D. is an urology in Dartmouth, MA with 14 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Andrew Christopher Boylan, M.D. NPI is 1669734786. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BOSTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2012

The provider's business location address is:

535 FAUNCE CORNER RD
DARTMOUTH, MA
ZIP 02747-242
Phone: (508) 996-3991

The NPI 1669734786 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Blood creatinine level (HCPCS:82565)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Insertion of tube into ureter using an endoscope through bladder area (HCPCS:52005)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Biopsy of prostate gland (HCPCS:55700)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 6/14/2012 and was last updated on 4/24/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: